Fislisbach, Switzerland

Laszlo Revesz


Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 129(Granted Patents)


Location History:

  • Fislisbach, CH (1981 - 1982)
  • Basel, CH (1982 - 1986)
  • Riehen, CH (1990)

Company Filing History:


Years Active: 1981-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Revesz

Introduction

Laszlo Revesz is a notable inventor based in Fislisbach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of five patents to his name, Revesz has focused on developing compounds that offer therapeutic benefits.

Latest Patents

Among his latest patents are the Morphinan derivatives, which include compounds of formula I wherein X and Y each denote hydrogen or together denote -0-. Another significant patent is for Acylaminophenol derivatives, which are compounds of formula I wherein n=1 to 5, possessing analgesic activity with reduced hepatotoxicity compared to paracetamol. These innovations reflect his commitment to improving drug safety and efficacy.

Career Highlights

Revesz has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and BBC Brown, Boveri & Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Laszlo Revesz has collaborated with esteemed colleagues such as Maged A. Osman and Terry J. Scheffer. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Laszlo Revesz's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of safer and more effective medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…